Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Rearrangements of the anaplastic lymphoma kinase (ALK) belong to the promising targets in the therapy of advanced non-small cell lung cancer (NSCLC) and are predominantly detected by immunohistochemistry (IHC) and/or fluorescence in-situ hybridization (FISH). | RNA-based analysis of ALK fusions in nonsmall cell lung cancer cases showing IHC FISH discordance